MeiraGTx Holdings Dirección
Dirección controles de criterios 3/4
El CEO de MeiraGTx Holdings es Alexandria Forbes , nombrado en Mar 2015, tiene una permanencia de 9.67 años. compensación anual total es $6.34M, compuesta por 10.2% salario y 89.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.79% de las acciones de la empresa, por valor de $8.31M. La antigüedad media del equipo directivo y de la junta directiva es de 5.5 años y 9.4 años, respectivamente.
Información clave
Alexandria Forbes
Chief Executive Officer (CEO)
US$6.3m
Compensación total
| Porcentaje del salario del CEO | 10.2% |
| Permanencia del CEO | 9.7yrs |
| Participación del CEO | 1.8% |
| Permanencia media de la dirección | 5.5yrs |
| Promedio de permanencia en la Junta Directiva | 9.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Analysts Have Lowered Expectations For MeiraGTx Holdings plc (NASDAQ:MGTX) After Its Latest Results
Nov 15
MeiraGTx: Positive PD Data Moves Needle Forward For Regulatory Meetings
Oct 15MeiraGTx: A Very Attractive Longer-Term Play, With Potential Near-Term Catalysts
Jul 15MeiraGTx Holdings (NASDAQ:MGTX) Has Debt But No Earnings; Should You Worry?
Jun 19MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met
Feb 15Does MeiraGTx Holdings (NASDAQ:MGTX) Have A Healthy Balance Sheet?
Sep 08Calculating The Intrinsic Value Of MeiraGTx Holdings plc (NASDAQ:MGTX)
Apr 11MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Reducing Their Forecasts For This Year
Mar 16MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are More Bearish Than They Used To Be
Nov 16MeiraGTx GAAP EPS of -$0.76, revenue of $10.76M
Aug 11MeiraGTx inks $100M debt agreement backed by manufacturing facilities
Aug 03MeiraGTx Holdings (NASDAQ:MGTX) Is In A Good Position To Deliver On Growth Plans
Apr 29Analysts' Revenue Estimates For MeiraGTx Holdings plc (NASDAQ:MGTX) Are Surging Higher
Mar 15Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$88m |
| Jun 30 2024 | n/a | n/a | -US$93m |
| Mar 31 2024 | n/a | n/a | -US$74m |
| Dec 31 2023 | US$6m | US$648k | -US$84m |
| Sep 30 2023 | n/a | n/a | -US$132m |
| Jun 30 2023 | n/a | n/a | -US$125m |
| Mar 31 2023 | n/a | n/a | -US$129m |
| Dec 31 2022 | US$8m | US$580k | -US$130m |
| Sep 30 2022 | n/a | n/a | -US$112m |
| Jun 30 2022 | n/a | n/a | -US$101m |
| Mar 31 2022 | n/a | n/a | -US$87m |
| Dec 31 2021 | US$6m | US$580k | -US$80m |
| Sep 30 2021 | n/a | n/a | -US$80m |
| Jun 30 2021 | n/a | n/a | -US$61m |
| Mar 31 2021 | n/a | n/a | -US$66m |
| Dec 31 2020 | US$8m | US$602k | -US$58m |
| Sep 30 2020 | n/a | n/a | -US$53m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$52m |
| Dec 31 2019 | US$8m | US$580k | -US$55m |
| Sep 30 2019 | n/a | n/a | -US$70m |
| Jun 30 2019 | n/a | n/a | -US$75m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | US$23m | US$555k | -US$85m |
| Sep 30 2018 | n/a | n/a | -US$73m |
| Jun 30 2018 | n/a | n/a | -US$66m |
| Mar 31 2018 | n/a | n/a | -US$42m |
| Dec 31 2017 | US$1m | US$450k | -US$32m |
Compensación vs. Mercado: La compensación total de Alexandria($USD6.34M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.16M).
Compensación vs. Ingresos: La compensación de Alexandria ha sido consistente con los resultados de la empresa en el último año.
CEO
Alexandria Forbes (59 yo)
9.7yrs
Permanencia
US$6,336,832
Compensación
Dr. Alexandria Forbes, Ph.D. serves as the Chief Executive Officer, Director and President at MeiraGTx Holdings plc (formerly known as MeiraGTx Limited) since March 2015. Prior to joining MeiraGTx, Dr. For...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 9.7yrs | US$6.34m | 1.79% $ 8.3m | |
| COO & CFO | 9.7yrs | US$4.98m | 1.19% $ 5.5m | |
| Chief Development Officer | 9.6yrs | US$2.50m | 0.72% $ 3.3m | |
| General Counsel & Secretary | 5.3yrs | sin datos | 0.019% $ 89.8k | |
| Head of Clinical Ophthalmology | 3.8yrs | sin datos | sin datos | |
| Senior Vice President of Global Integration | no data | sin datos | sin datos | |
| Senior Vice President of Risk & Internal Controls | 5.6yrs | sin datos | sin datos | |
| Senior Vice President of Manufacturing & Supply Chain | 5.3yrs | sin datos | sin datos | |
| Chief Medical Officer | 4.3yrs | US$4.05m | 0.11% $ 532.0k |
5.5yrs
Permanencia media
58yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de MGTX es experimentado (5.5 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, President & Director | 9.7yrs | US$6.34m | 1.79% $ 8.3m | |
| Member of Scientific Advisory Board | no data | US$149.82k | 0% $ 0 | |
| Independent Director & Member of Scientific Advisory Board | 9.4yrs | US$347.73k | 0% $ 0 | |
| Independent Chairman of the Board | 9.4yrs | US$538.84k | 0.064% $ 296.5k | |
| Independent Director | 5.5yrs | US$395.76k | 0.0064% $ 29.7k | |
| Chairman of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 9.4yrs | US$352.73k | 0.016% $ 76.4k | |
| Director | 7.1yrs | US$264.23k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos |
9.4yrs
Permanencia media
68yo
Promedio de edad
Junta con experiencia: La junta directiva de MGTX se considera experimentada (9.4 años de antigüedad promedio).